From: Underuse of medication for circulatory disorders among unmarried women and men in Norway?
 |  | Men Never-married | Widowed | Divorced/separated | Women Never-married | Widowed | Divorced/separated |
---|---|---|---|---|---|---|---|
Panel A: Purchase of medicine in 2004-2008 (signs as in estimates in Table 2 ) | |||||||
Coronary and peripheral vascular diseases, antiplatelet | Â | - - - | Â | Â | - - - | + + + | + + + |
Coronary and peripheral vascular diseases, anticoagulant | Â | - - - | + | + + | - - - | + + + | + + + |
Hypertension | Â | Â | + + + | - - - | - | + + + | - - - |
Hyperlipedemia | Â | - - - | - - - | - - - | - - - | - - - | - - - |
Anti-arrhythmic cardiac diseases | Â | Â | + + | + + | Â | + + + | + + |
IHD/Angina | Â | - - - | Â | Â | - - - | + + + | + + + |
Congestive heart failure/hypertension | Â | - - - | + + + | - - - | - - - | + + + | Â |
Other IHD/hypertension | Â | - - - | + + + | - - - | - - - | + + + | - - - |
Panel B: Starting and continuing purchase of medicine 2005-2008 a | |||||||
Coronary and peripheral vascular diseases, antiplatelet | Start | - - - | Â | + + + | - - - | + + + | + + + |
Continuation | + + | Â | Â | + + + | Â | + + + | |
Coronary and peripheral vascular diseases, anticoagulant | Start | - - - | Â | + + + | Â | + + + | + + + |
Continuation | Â | Â | - - - | + | Â | Â | |
Hypertension | Start | Â | + + + | Â | - | + + | - |
Continuation | + + + | Â | - - - | + + | Â | - - - | |
Hyperlipedemia | Start | - - - | Â | Â | - - - | - - | - |
Continuation | - - - | - - - | - - - | Â | - - - | - - - | |
Anti-arrhythmic cardiac diseases | Start | Â | + + + | + + + | Â | + + + | + + + |
Continuation | + + + | Â | - - | Â | Â | Â | |
IHD/Angina | Start | - - - | Â | Â | - - - | + + + | + + + |
Continuation | + + + | Â | Â | + + + | + | Â | |
Congestive heart failure/hypertension | Start | - - - | + + + | + + + | Â | + + + | + + |
Continuation | - - - | - - - | - - - | - - - | - - - | - - - | |
Other IHD/hypertension | Start | - - - | + + + | + + + | - - - | + + + | + + |
 | Continuation |  | - - - | - - - |  |  | - - - |